We report the appearance of a Mycoplasma haemocanis infection in laboratory dogs, which has been reported previously, yet, never before in Europe. Outbreak of the disease was triggered by a splenectomy intended to prepare the dogs for a hemorrhagic shock study. The clinical course of the dogs was dramatic including anorexia and hemolytic anemia. Treatment included allogeneic transfusion, prednisone, and oxytetracycline. Systematic follow-up (n = 12, blood smears, antibody testing and specific polymerase chain reaction) gives clear evidence that persistent eradication of M. haemocanis is unlikely. We, therefore, had to abandon the intended shock study. In the absence of effective surveillance and screening for M. haemocanis, the question arises whether it is prudent to continue shock research in splenectomized dogs.
Introduction
Pathophysiology and therapy of hemorrhagic shock is -and will remain -a core field of interest in surgical research. In vivo models are performed in small rodents, but also in large mammalians. The latter remains indispensable, since investigation of O 2 transport, regional peripheral perfusion and tissue oxygenation requires extensive surgical instrumentation and sufficient dimensions of the organs of interest. Traditionally, dogs are the preferred animals in the design of experimental hemorrhagic shock models. Efforts to standardize the experimental shock insult included control of volume depletion [1] , control of blood pressure reduction [2] , and control of accumulated O 2 debt [3, 4] .
However, investigators are still confronted with considerable variability in the canine cardiovascular shock response, since the canine spleen acts as a blood reservoir and contracts during hemorrhage, expelling red cells, thus increasing hematocrit, circulating blood volume, left ventricular preload, cardiac output and arterial O 2 content [5] [6] [7] , which dramatically enhances the canine cardiovascular stress response [6, 8] . Canine splenic contraction is mediated by endothelin and by norepinephrine via · 1 -adrenoceptors [9] . Of note, the splenic release of red cells is variable in dogs and negligible in humans [5] . Therefore, to allow extrapolation of results from canine experiments to the human setting, splenectomy prior to induction of hemorrhagic shock is a frequently used procedure. In 1975, Pryor and Bradbury [10] published a systematic report on 20 splenectomized beagle dogs from the US Naval Medical Field Research Laboratory and Medical Research Center suffering from a parasitemic disease that caused anemia.
Mycoplasma haemocanis (formerly Haemobartonella canis) is well known to veterinary physicians all over the world [11] [12] [13] . It is assumed that infection of dogs with M. haemocanis is not an unusual event. However, clinical outbreak of the disease requires previous immunosuppression, coexistent infection, or, most importantly, splenectomy [14] [15] [16] . The disease was infrequently recognized and thought to be of limited relevance in researchan epidemic outbreak in a European research institution has not been reported until today. We describe an impressive episode of epidemic M. haemocanis infection in our laboratory, complicating a large experimental study. We had to terminate our project prematurely, fearing that this infection would be a confounding factor when analyzing the experimental results. The question arises whether it is prudent to go on conducting research involving the use of splenectomized dogs in the future.
Methods

Design
The purpose-bred dogs were purchased from an established commercial breeder in Germany to be included in a hemorrhagic shock study. For prophylaxis against ectoparasites, fenthion 200 mg (Bayer, Leverkusen, Germany) was administered externally at the time of admission to our laboratory. Subsequently, the animals were allowed to recover from transportation for 48 h, and underwent routine splenectomy afterwards. Triggered by this procedure, overt disease with M. haemocanis was observed, diagnosed and treated as documented below (case report, n = 2). In an attempt to continue the planned project, we purchased 12 additional dogs from the same breeder. To identify whether a potential contact with M. haemocanis might have occurred prior to arrival at our institution, we took samples of whole blood and serum, including blood smears from all dogs within the 1st h after arrival. Animals were splenectomized. M. haemocanis was detected. Treatment was initiated and systematic follow-up was performed (prospective follow-up over 120 days; n = 12).
Splenectomy, Postoperative Care
Following overnight starvation, splenectomy was performed under aseptic conditions under general anesthesia (propofol, fentanyl) and antibiotic prophylaxis (cefuroxim 750 mg), followed by daily clinical evaluations of the dogs. All animals recovered in relation to their preoperative condition. There were no postoperative events of bleeding, suture dehiscence, peritonitis, ileus or wound infection.
After at least 6 weeks of recovery the animals were to undergo the planned hemorrhagic shock experiment. This stepwise experimental procedure has been routinely performed by our group for several years [17] .
Detection of Anti-M. haemocanis Antibodies
To give indirect evidence for the presence of M. haemocanis, we obtained serum samples, which were submitted for serologic testing. Since M. haemocanis cross-reacts with Rickettsia conori, sera were subjected to the indirect fluorescent antibody test in which R. conori was used as antigen (Rickettsia conori-Spot IF, bioMerieux, Lyon, France). FITC-labeled goat anti-dog IgM antibody and FITC-labeled goat anti-dog IgG antibody (KPL, Gaithersburg, Md., USA) were used to detect the presence of dog anti-M. haemocanis IgM and IgG antibodies in the dog sera using a fluorescence microscope.
Specific Polymerase Chain Reaction Assay
Identification of the microorganism was performed using standard polymerase chain reaction (PCR) testing. DNA was extracted from 2 ml of whole blood by a standard proteinase K treatment. The technique has recently been described as being able to give evidence of the presence of M. haemocanis (formerly H. canis) in dogs [18] and Mycoplasma haemofelis in cats [19, 20] using a specific representative gene sequence that is largely congruent with minor variations for both subspecies [21] . We chose a segment of 677 bp out of the 16S rRNA gene to identify the parasite. Referring primers were generated based on a BLAST genomic database search [22] at the National Library of Medicine (http://www.ncbi.nlm.nih.gov), National Center of Biotechnological Information.
To verify our method and diagnosis, we divided our blood samples and sent 8 whole blood samples for cross-checking to Prof. Dr. J. Messick (VMD, University of Illinois, Urbana-Champaign, Ill., USA), who performed simultaneous PCR. Additional cross-checking was made by a 3rd investigator (Prof. Dr. S. Shaw, Dr. S. Tasker, Acarus Unit, Department of Clinical Veterinary Science, University of Bristol, UK).
Data Analysis, Statistics
Data are presented as single observations over time in dogs 1279 and 1295. Data taken from the newly purchased and prospectively investigated group (n = 12) are depicted as means and standard deviations. Differences of measured values over time were analyzed with a repeated measurements ANOVA (SAS-System TM , Cary, N.Y., USA). The ·-error threshold was set to 5%.
Results
Case Report
On day 49 after splenectomy, one dog (No. 1279) presented with apathy, inappetence, and a grossly reduced physical condition. Our institutional veterinary consultant found pale conjunctivae, cachexia, and fever (39.8°C) with no obvious external bleeding. At that time, the hemoglobin concentration was 3.8 g dl -1 (day 49, repeated measurements). Several weeks later, dog 1295, a littermate of the previous dog, displayed very similar clinical symptoms and blood analysis revealed a hemoglobin concentration of 6.1 g dl -1 (day 133; table 1).
While abdominal sonography and chest X-ray displayed no pathological findings in dog 1279, the peripheral blood count showed profound anemia including a prominent left shift of white blood cell distribution (table 1) . A bone marrow biopsy showed reduced cellularity with a pronounced increase in erythropoiesis (65%) and, to some extent, in lymphopoiesis (20%). Granulopoiesis was displaced (15%) and megakaryopoiesis was undetectable (0%). Giemsa-stained blood smears of both dogs showed anisocytosis, poikilocytosis, hypochromasia, Jolly bodies, and basophilic or polychromatophilic epierythrocytic and erythrocytic inclusion bodies, which were later identified as resembling M. haemocanis ( fig. 1 ). Due to a diagnosis of life-threatening anemia, dog 1279 immediately received 200 ml packed allogeneic red cells (centrifuged at 4,000 g over 10 min) pooled from the seemingly healthy littermates as a single transfusion; methylprednisolone 100 mg was given intravenously to prevent transfusion reactions. Prednisone 2 mg kg -1 daily was continued orally for 4 days to terminate para-infectious hemolytic anemia, and was then tapered off over a period of 10 days. Dog 1295 was treated with oxytetracycline and prednisone alone. Oxytetracycline 40 mg kg -1 daily was given over a period of at least 42 days in all animals. After that time, dogs 1279 and 1295 became vital with no clinical signs of acute anemia or infection, and were included in the planned study. Hemograms (table 1) and standard O 2 transport parameters were all within reference values at that time.
Systematic Postoperative Follow-Up
All 12 animals were deemed healthy on arrival and underwent splenectomy without adverse events. On the 1st postoperative day, we noticed marked leukocytosis (38 ! 10 9 l -1 ) and left shift (15% juveniles) accompanied by a temporary drop in hemoglobin concentration by 3 g dl -1 . On day 21, a second peak in white blood cell count and a reduction in platelet count became evident together with a rise in rectal temperature to 38.8°C ( fig. 2) and a marked increase in lymphocyte count. We observed M. haemocanis-positive blood smears on day 21 (4/12) and 35 (7/12), and significant antibody titers on day 35 (12/12). Treatment was commenced and maintained until day 98. At approximately day 70 another peak in white blood cell count became evident in the presence of critical thrombocytopenia and slight eosinophilia ( fig. 2 ). Blood smears still remained positive for M. haemocanis (7/12), despite prolonged antimicrobial therapy ( fig. 3 ).
On day 119, blood smears (3/12), serum antibody status (7/12) and specific PCR testing (8/12) were still positive for M. haemocanis ( fig. 4) . The latter was confirmed in a second PCR (University of Illinois; 7/12); all 7 positive results were confirmed by cloning of almost the entire 16S rRNA gene and subsequent sequence analysis, and by a third PCR (AY 150989 and AY 150988) [23] .
Time of Infection
Eight of the 12 serum samples that had been taken within the 1st h after animal arrival at our facility were lost during overseas transport. In 2 of the remaining 4 animal serum specimens, significant titers of antibodies of the IgM type cross-reactive for M. haemocanis were detected in the absence of clinical disease (fig. 4) .
Termination of Experimental Project
After confirmation of the diagnosis by 3 distinct laboratories and at the time when persistence of M. haemocanis was evidenced despite completed antimicrobial therapy, the institutional board for animal protection and the Bavarian Government were informed and the experimental series was terminated.
Discussion
Diagnosis of the Disease
Historically, the diagnosis of M. haemocanis relies on smears of peripheral blood, in which M. haemocanis mostly appears in coccoid form (0.2-0.4 Ìm), as rings, doughnut forms, or rods [24, 25] , but also as streptococcal-like chains or bows [24, 26] . M. haemocanis is typically located in the deeply indented folds of the erythrocyte surface. The parasite is Gram-negative and can be visualized by classic Giemsa staining. Serologic testing for anti-M. haemocanis cross-reactive antibodies may be helpful. However, today the superior technique for obtaining unequivocal evidence of the presence of M. haemocanis is PCR of whole blood [18] [19] [20] .
Mode of Transmission
It is generally accepted that M. haemocanis is transmitted by blood-feeding arthropods, especially the dog tick, Rhipicephalus sanguineus [12, 13] . It may, however, be transmitted by oral ingestion or directly penetrating blood inoculation [12, 13] . There is also evidence for a possible materno-fetal transplacental transmission [27] .
Appearance of Clinical Disease
In principle, the disease may occur in two forms: a latent form, which may be almost void of symptoms, and an acute form, the clinical appearance of which has been reviewed in detail [13, 15] and is documented in our case report. Symptoms may occur quickly (1-2 weeks) [10, 26] or, as in this case, with a delay (4-9 weeks) [18, 28] .
Like others, we observed severe anemia, leukopenia [29, 30] , and also leukocytosis [15, 28] together with an initial temporary left shift of white blood cell distribution and delayed lymphocytosis [14, 30] . A reduced platelet count is a frequent observation in dogs bearing M. haemocanis and may be associated with bleeding disorders [15, 28] .
Pathophysiological Consequences of Infection
To date, it is not clear what damage is done to red cells that are infected with M. haemocanis. Growth of the microorganism seems possible without destruction of the erythrocyte membrane. However, the cyclic nature of the disease and apparent episodes of severe anemia suggest the possibility that red cells might simply be destroyed by the adhering microorganism at a critical point without phagocytosis, or perhaps there is hemolysis by isoagglutinines [24] . It is undeniable, however, that M. haemocanis severely alters the shape and deformability of affected red cells and causes anemia. It is obvious that this may interfere with tissue perfusion and oxygen unloading at the microcirculatory level.
Predisposition
The prevalence of M. haemocanis in the canine population remains to be determined [13] . In the laboratory setting it might be difficult to prevent the occurrence of M. haemocanis, since infection occurs predominantly in immunosuppressed and splenectomized dogs [13] [14] [15] . As has been tested by our group in animals from different kennels (unpublished data), and as reported herein, kennel-raised dogs may have a higher prevalence of infection than other dog populations [13] . This speculation needs to be investigated further.
Therapy
The therapy of choice is oxytetracycline at 20-40 mg kg body weight, or doxycycline 5-10 mg kg body weight/ day [13, 15] . Administration of prednisone aims to limit hemolysis and erythrocyte phagocytosis. It should be restricted to several days and tapered off when hemoglobin levels start to rise [13] . Of note, systemic antimicrobial therapy may not necessarily fully eliminate M. haemocanis from the blood [15] , as confirmed by our present results (PCR, blood smears). A relapse may occur as late as 6 months after infection [28] . Splenectomy may contribute to the difficulties in eradication. In summary, the course of the disease is largely unpredictable.
Practical Implications
At present, researchers in the field do need to establish efficacious surveillance and need to conclusively show the absence of infection with M. haemocanis to ensure the validity of scientific results in the future. A proposal to reduce the prevalence of M. haemocanis in a research laboratory should include repeated eradication of potential vectors like the dog tick R. sanguineus, separate housing, frequent blood sampling and evaluation of blood smears, but most importantly, PCR testing. PCR is commercially available from veterinary laboratories, though this may be costly (F40 EUR). Since PCR primers can be identified at the NCBI (see above) and can be purchased, an inhouse PCR test for M. haemocanis may be established in any laboratory where a PCR cycler exists and expertise is at hand. The time required for cycling and reading does not exceed 6 h. Up to 96 tests might be run simultaneously, and costs for a single tests can be kept low (F2 EUR) as compared to commercial laboratories. However, the frequency and timing of PCR testing needed to ensure detection of an infection in principle remain to be determined since parasitemia is transient, which may prevent the detection of M. haemocanis. At present, there is a long way to go before a surveillance for M. haemocanis can become operative in everyday routine. Therefore, it is the authors' opinion that at present the conduction of experimental studies in splenectomized or potentially immunosuppressed dogs is, in general, not recommended.
Conclusion
We report on the first clinical outbreak of M. haemocanis in a European surgical research laboratory. Successful treatment is possible, however, full eradication of M. haemocanis is difficult to achieve. Reports on the cumulated outbreak of this disease in immunosuppressed and splenectomized dogs are growing. In experimental cardiovascular studies on dogs, splenectomy is a frequently used procedure which may uncover a chronic M. haemocanis infection. Thus, particularly with regard to animal protection issues, we need to carefully consider whether it is prudent to continue performing experiments in splenectomized or immunosuppressed dogs.
